A detailed history of Kampmann Melissa S. transactions in Eli Lilly & CO stock. As of the latest transaction made, Kampmann Melissa S. holds 9,746 shares of LLY stock, worth $7.36 Million. This represents 6.11% of its overall portfolio holdings.

Number of Shares
9,746
Previous 9,986 2.4%
Holding current value
$7.36 Million
Previous $9.04 Billion 4.5%
% of portfolio
6.11%
Previous 6.6%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$772.14 - $960.02 $185,313 - $230,404
-240 Reduced 2.4%
9,746 $8.63 Billion
Q2 2024

Aug 16, 2024

SELL
$724.87 - $909.04 $644,409 - $808,136
-889 Reduced 8.17%
9,986 $9.04 Billion
Q1 2024

May 15, 2024

SELL
$592.2 - $792.28 $169,961 - $227,384
-287 Reduced 2.57%
10,875 $8.46 Billion
Q4 2023

Feb 22, 2024

SELL
$525.19 - $619.13 $646,508 - $762,149
-1,231 Reduced 9.93%
11,162 $6.51 Billion
Q3 2023

Nov 20, 2023

BUY
$434.7 - $599.3 $5.39 Million - $7.43 Million
12,393 New
12,393 $6.66 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $717B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Kampmann Melissa S. Portfolio

Follow Kampmann Melissa S. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kampmann Melissa S., based on Form 13F filings with the SEC.

News

Stay updated on Kampmann Melissa S. with notifications on news.